SCHEMBL3677602

SCHEMBL3677602

[CH2]CCCCCC(O)[CH]O

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.30
DDAH1 O94760 1/20 0.30
GAPDH P04406 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3754462 1.00 TRPA1 (0.30) TRPA1DDAH1GAPDHMAPT
SCHEMBL10865968 1.00 TRPA1 (0.30) TRPA1DDAH1GAPDHMAPT
SCHEMBL3769249 1.00 TRPA1 (0.30) TRPA1DDAH1GAPDHMAPT
SCHEMBL3675527 0.97
SCHEMBL3736283 0.92
SCHEMBL624558 0.80
SCHEMBL196198 0.79
SCHEMBL8453338 0.78 TRPV1 (0.31) TRPA1
SCHEMBL11163355 0.78 TRPV1 (0.31) TRPA1
SCHEMBL8403266 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025233552-A1 WHITE GRAPE EXTRACT AND USES OF SAME UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) 2025-11-13 WO disclosed
WO-2025233553-A1 INTRAMAMMARY FORMULATIONS FOR MASTITIS UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) 2025-11-13 WO disclosed
EP-2875822-B1 POLYPHENOL EXTRACT FROM WHITE-GRAPE RESIDUE UNIV SANTIAGO COMPOSTELA (ES) 2022-11-02 EP disclosed
EP-2838547-B1 COMPOUNDS FOR THE TREATMENT AND/OR CARE OF THE SKIN AND/OR MUCOUS MEMBRANES AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS LUBRIZOL ADVANCED MAT INC (US) 2019-09-04 EP disclosed
US-9725483-B2 Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions LIPOTEC, S.A. (ES) 2017-08-08 US disclosed
EP-2875822-A1 POLYPHENOL EXTRACT FROM WHITE-GRAPE RESIDUE Universidade De Santiago De Compostela (ES) 2015-05-27 EP disclosed
US-20150104485-A1 COMPOUNDS FOR THE TREATMENT AND/OR CARE OF THE SKIN AND/OR MUCOUS MEMBRANES AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS LUBRIZOL ADVANCED MATERIALS, INC. (US) 2015-04-16 US disclosed
WO-2014013122-A1 POLYPHENOL EXTRACT FROM WHITE-GRAPE RESIDUE UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) 2014-01-23 WO disclosed
US-20100304017-A1 URETHANE AND OLIGOURETHANE DERIVATIVES AND CORRESPONDING USES AND METHODS FOR PRODUCING WATER MARKS USING THE OFFSET PRINTING TECHNIQUE OLIVA GURGUI, ANTONIO (ES) 2010-12-02 US disclosed
US-7723423-B2 Gas-barrier resin composition CRYOVAC, INC. (US) 2010-05-25 US disclosed
EP-1746131-B1 Gas-barrier resin composition CRYOVAC INC (US) 2009-01-21 EP disclosed
US-20070093599-A1 Gas-barrier resin composition CRYOVAC, INC. (US) 2007-04-26 US disclosed
EP-1746131-A2 Gas-barrier resin composition Cryovac, Inc. (US) 2007-01-24 EP disclosed
WO-2006111600-A1 METHOD AND CATALYSTS FOR THE EPOXIDATION OF OLEFINIC COMPOUNDS IN THE PRESENCE OF OXYGEN CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) 2006-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150104485-A1 COMPOUNDS FOR THE TREATMENT AND/OR CARE OF THE SKIN AND/OR MUCOUS MEMBRANES AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS MC1R, TYR, MC3R TRPA1 91/4885DDAH1 3936/4885GAPDH 1777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.